Peddio Stefania, Lorrai Sonia, Dettori Tinuccia, Contini Cristina, Olianas Alessandra, Manconi Barbara, Rescigno Antonio, Zucca Paolo
Department of Biomedical Sciences (DiSB), University Campus, Monserrato, 09042 Cagliari, Italy.
Laboratoire de Production et de Biostimulation des Plantes cultivées, Faculté des Sciences, Université Libre de Bruxelles, 1050 Bruxelles, Belgium.
Plants (Basel). 2024 Jul 26;13(15):2074. doi: 10.3390/plants13152074.
The increasing need for new treatments for obesity and diabetes has led to the development of new drugs and food supplements that could reduce carbohydrate absorption. Many starch blockers, based on common bean proteinaceous inhibitors against α-amylase (α-AI), are already present on the market. The extraction and purification of α-amylase inhibitor from a promising common bean cultivar from Sardinia (Nieddone) is described, highlighting the unique value of the Nieddone cultivar, particularly for its inhibitory activity on digestive enzymes and its complete lack of a hemagglutination effect on human red blood cells. The purification of α-AI involved two chromatographic steps (IEC and SEC) and was essential for revealing certain properties of the inhibitor. The purified inhibitor has a tetrameric structure (αβ) and a molecular weight of approximately 42 kDa, as determined by SEC and SDS-PAGE, confirming it as a lectin-like inhibitor. The identification of the α-AI sequence was obtained by bottom-up high-resolution mass spectrometry, which allowed us to identify a unique peptide from the α chain and six unique peptides from the β chains. α-AI exhibited an optimum temperature of around 40 °C and two pH optima at 5 and 6.5, respectively. Its remarkable stability at high temperatures was measured (approximately 25% of activity retained even after 5 h at 100 °C), whereas the raw extract lost its activity entirely after just 10 min at 90 °C. Thus, the purification process significantly enhances the thermal stability of α-AI. The demonstrated effectiveness of the purified α-AI against the α-amylase enzyme in pigs, humans and insects underscores the protein's potential for treating obesity and diabetes, as well as for managing insect pests.
对肥胖症和糖尿病新疗法的需求不断增加,促使人们研发出能够减少碳水化合物吸收的新药和食品补充剂。许多基于菜豆中抗α-淀粉酶(α-AI)的蛋白质抑制剂的淀粉阻滞剂已投放市场。本文描述了从撒丁岛一种有前景的菜豆品种(尼德多内)中提取和纯化α-淀粉酶抑制剂的过程,突出了尼德多内品种的独特价值,特别是其对消化酶的抑制活性以及对人类红细胞完全没有血凝作用。α-AI的纯化涉及两个色谱步骤(离子交换色谱和尺寸排阻色谱),这对于揭示抑制剂的某些特性至关重要。通过尺寸排阻色谱和十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定,纯化后的抑制剂具有四聚体结构(αβ),分子量约为42 kDa,证实其为一种类凝集素抑制剂。通过自下而上的高分辨率质谱法获得了α-AI序列的鉴定结果,这使我们能够从α链中鉴定出一个独特的肽段,从β链中鉴定出六个独特的肽段。α-AI的最佳温度约为40℃,分别在pH值为5和6.5时表现出两个最佳pH值。测定了其在高温下的显著稳定性(即使在100℃下5小时后仍保留约25%的活性),而粗提物在90℃下仅10分钟就完全失去了活性。因此,纯化过程显著提高了α-AI的热稳定性。纯化后的α-AI对猪、人和昆虫体内的α-淀粉酶酶的有效性证明,突出了该蛋白质在治疗肥胖症和糖尿病以及防治害虫方面的潜力。